speb/financial-data huggingface dataset:
CRAMC.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 132340000.00
CRAMC.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 132340000.00
CRAMC.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 132340000.00
CRAMC.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 2396000.00
CRAMC.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 2396000.00
CRAMC.NS balance_sheet (annual, 2026-03-31) — Machinery Furniture Equipment: 52190000.00
CRAMC.NS balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 52190000.00
CRAMC.NS cash_flow (annual, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: -4992000.00
CRAMC.NS income_statement (annual, 2026-03-31) — Net Income: 2038047000.00
CRAMC.NS income_statement (quarterly, 2026-03-31) — Net Income: 413613000.00
CRAMC.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 2038047000.00
CRAMC.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 413613000.00
CRAMC.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 2038047000.00
CRAMC.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 413613000.00
CRAMC.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 2038047000.00
CRAMC.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 413613000.00
CRAMC.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 2038047000.00
CRAMC.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 413613000.00
CRAMC.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 2746269000.00
CRAMC.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 2038047000.00
CRAMC.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 413613000.00
CRAMC.NS income_statement (annual, 2026-03-31) — Net Interest Income: -17753000.00
CRAMC.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -4820000.00
CRAMC.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: -1023803000.00
CRAMC.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -17753000.00
CRAMC.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -4820000.00
CRAMC.NS balance_sheet (annual, 2026-03-31) — Net PPE: 163918000.00
CRAMC.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 163918000.00
CRAMC.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -60625000.00
CRAMC.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 7421867000.00
CRAMC.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 7421867000.00
CRAMC.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 42600000.00
CRAMC.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 42600000.00
CRAMC.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 2552758000.00
CRAMC.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 712402000.00
CRAMC.NS income_statement (annual, 2026-03-31) — Normalized Income: 1824853543.60
CRAMC.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 488738690.33
CRAMC.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 1722812000.00
CRAMC.NS income_statement (annual, 2026-03-31) — Operating Income: 2468719000.00
CRAMC.NS income_statement (quarterly, 2026-03-31) — Operating Income: 690518000.00
CRAMC.NS income_statement (annual, 2026-03-31) — Operating Revenue: 4249450000.00
CRAMC.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 1142039000.00
CRAMC.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 199417428.00
CRAMC.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 199417428.00
CRAMC.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 90377000.00
CRAMC.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 90377000.00
CRAMC.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 354901000.00
CRAMC.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 354901000.00
CRAMC.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 18667000.00
CRAMC.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 18667000.00
CRAMC.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 36369000.00
CRAMC.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 36369000.00
CRAMC.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: 21377000.00
CRAMC.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 3353000.00
CRAMC.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 3353000.00
CRAMC.NS balance_sheet (annual, 2026-03-31) — Other Non Current Liabilities: 17862000.00
CRAMC.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 17862000.00
CRAMC.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 8019000.00
CRAMC.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 2147000.00
CRAMC.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 425861000.00
CRAMC.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 194040000.00
CRAMC.NS balance_sheet (annual, 2026-03-31) — Other Properties: 121971000.00
CRAMC.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 121971000.00
CRAMC.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 5900532000.00
CRAMC.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 5900532000.00
CRAMC.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
CRAMC.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
CRAMC.NS balance_sheet (annual, 2026-03-31) — Payables: 19316000.00
CRAMC.NS balance_sheet (quarterly, 2026-03-31) — Payables: 19316000.00
CRAMC.NS balance_sheet (annual, 2026-03-31) — Prepaid Assets: 0.00
CRAMC.NS balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 0.00
CRAMC.NS income_statement (annual, 2026-03-31) — Pretax Income: 2746269000.00
CRAMC.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 582114000.00
CRAMC.NS balance_sheet (annual, 2026-03-31) — Properties: 0.00
CRAMC.NS balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
CRAMC.NS cash_flow (annual, 2026-03-31) — Purchase Of Investment: -25058854000.00
CRAMC.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -60759000.00
CRAMC.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 909854000.00
CRAMC.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 237744000.00
CRAMC.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 32955000.00
CRAMC.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 19737000.00
CRAMC.NS income_statement (annual, 2026-03-31) — Rent And Landing Fees: 5327000.00
CRAMC.NS income_statement (annual, 2026-03-31) — Rent Expense Supplemental: 5327000.00
CRAMC.NS balance_sheet (annual, 2026-03-31) — Restricted Cash: 99000.00
CRAMC.NS balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 99000.00
CRAMC.NS balance_sheet (annual, 2026-03-31) — Retained Earnings: 5430920000.00
CRAMC.NS balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 5430920000.00
CRAMC.NS cash_flow (annual, 2026-03-31) — Sale Of Investment: 24035051000.00
CRAMC.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 134000.00
CRAMC.NS income_statement (annual, 2026-03-31) — Selling And Marketing Expense: 101043000.00
CRAMC.NS income_statement (annual, 2026-03-31) — Selling General And Administration: 177188000.00
CRAMC.NS balance_sheet (annual, 2026-03-31) — Share Issued: 199417428.00
CRAMC.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 199417428.00
CRAMC.NS income_statement (annual, 2026-03-31) — Special Income Charges: 0.00
CRAMC.NS cash_flow (annual, 2026-03-31) — Stock Based Compensation: 18667000.00
CRAMC.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 7458236000.00
CRAMC.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 7458236000.00
CRAMC.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 7421867000.00
CRAMC.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 7421867000.00
CRAMC.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 74090543.60
CRAMC.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -30605309.67
CRAMC.NS income_statement (annual, 2026-03-31) — Tax Provision: 708222000.00
CRAMC.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 168501000.00
CRAMC.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.26
CRAMC.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.29
CRAMC.NS balance_sheet (annual, 2026-03-31) — Taxes Receivable: 0.00
CRAMC.NS balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 0.00
CRAMC.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -718505000.00
CRAMC.NS balance_sheet (annual, 2026-03-31) — Total Assets: 8186054000.00
CRAMC.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 8186054000.00
CRAMC.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 7458236000.00
CRAMC.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 7458236000.00
CRAMC.NS balance_sheet (annual, 2026-03-31) — Total Debt: 175886000.00
CRAMC.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 175886000.00
CRAMC.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 7458236000.00
CRAMC.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 7458236000.00
CRAMC.NS income_statement (annual, 2026-03-31) — Total Expenses: 1780731000.00
CRAMC.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 451521000.00
CRAMC.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 727818000.00
CRAMC.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 727818000.00
CRAMC.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 1724544000.00
CRAMC.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 1724544000.00
CRAMC.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 195228000.00
CRAMC.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 195228000.00
CRAMC.NS balance_sheet (annual, 2026-03-31) — Total Tax Payable: 19316000.00
CRAMC.NS balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 19316000.00
CRAMC.NS income_statement (annual, 2026-03-31) — Total Unusual Items: 287284000.00
CRAMC.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items: -105731000.00
CRAMC.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: 287284000.00
CRAMC.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -105731000.00
CRAMC.NS balance_sheet (annual, 2026-03-31) — Working Capital: 5929019000.00
CRAMC.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 5929019000.00
CRAMC.NS income_statement (quarterly, 2026-06-30) — +Operating Expense: 177128000.00
CRAMC.NS income_statement (quarterly, 2026-06-30) — +Total Revenue: 1162014000.00
CRAMC.NS income_statement (quarterly, 2026-06-30) — Basic Average Shares: 199481266.00
CRAMC.NS income_statement (quarterly, 2026-06-30) — Basic EPS: 3.79
CRAMC.NS income_statement (quarterly, 2026-06-30) — Cost Of Revenue: 281534000.00
CRAMC.NS income_statement (quarterly, 2026-06-30) — Depreciation And Amortization In Income Statement: 24662000.00
CRAMC.NS income_statement (quarterly, 2026-06-30) — Depreciation Income Statement: 24662000.00
CRAMC.NS income_statement (quarterly, 2026-06-30) — Diluted Average Shares: 199481266.00
CRAMC.NS income_statement (quarterly, 2026-06-30) — Diluted EPS: 3.79
CRAMC.NS income_statement (quarterly, 2026-06-30) — Diluted NI Availto Com Stockholders: 756034000.00
CRAMC.NS income_statement (quarterly, 2026-06-30) — EBIT: 999759000.00
CRAMC.NS income_statement (quarterly, 2026-06-30) — EBITDA: 1024421000.00
CRAMC.NS income_statement (quarterly, 2026-06-30) — Gross Profit: 880480000.00
CRAMC.NS income_statement (quarterly, 2026-06-30) — Interest Expense: 6255000.00
CRAMC.NS income_statement (quarterly, 2026-06-30) — Interest Expense Non Operating: 6255000.00
CRAMC.NS income_statement (quarterly, 2026-06-30) — Net Income: 756034000.00
CRAMC.NS income_statement (quarterly, 2026-06-30) — Net Income Common Stockholders: 756034000.00
CRAMC.NS income_statement (quarterly, 2026-06-30) — Net Income Continuous Operations: 756034000.00
CRAMC.NS income_statement (quarterly, 2026-06-30) — Net Income From Continuing And Discontinued Operation: 756034000.00
CRAMC.NS income_statement (quarterly, 2026-06-30) — Net Income From Continuing Operation Net Minority Interest: 756034000.00
CRAMC.NS income_statement (quarterly, 2026-06-30) — Net Income Including Noncontrolling Interests: 756034000.00
CRAMC.NS income_statement (quarterly, 2026-06-30) — Net Interest Income: -6255000.00
CRAMC.NS income_statement (quarterly, 2026-06-30) — Net Non Operating Interest Income Expense: -6255000.00
CRAMC.NS income_statement (quarterly, 2026-06-30) — Normalized EBITDA: 732689000.00
CRAMC.NS income_statement (quarterly, 2026-06-30) — Normalized Income: 534032567.81
CRAMC.NS income_statement (quarterly, 2026-06-30) — Operating Income: 703352000.00
CRAMC.NS income_statement (quarterly, 2026-06-30) — Operating Revenue: 1162014000.00
CRAMC.NS income_statement (quarterly, 2026-06-30) — Other Non Operating Income Expenses: 4675000.00
CRAMC.NS income_statement (quarterly, 2026-06-30) — Other Operating Expenses: 152466000.00
CRAMC.NS income_statement (quarterly, 2026-06-30) — Otherunder Preferred Stock Dividend: 0.00
CRAMC.NS income_statement (quarterly, 2026-06-30) — Pretax Income: 993504000.00
CRAMC.NS income_statement (quarterly, 2026-06-30) — Reconciled Cost Of Revenue: 281534000.00
CRAMC.NS income_statement (quarterly, 2026-06-30) — Reconciled Depreciation: 24662000.00
CRAMC.NS income_statement (quarterly, 2026-06-30) — Tax Effect Of Unusual Items: 69730567.81
CRAMC.NS income_statement (quarterly, 2026-06-30) — Tax Provision: 237470000.00
CRAMC.NS income_statement (quarterly, 2026-06-30) — Tax Rate For Calcs: 0.24
CRAMC.NS income_statement (quarterly, 2026-06-30) — Total Expenses: 458662000.00
CRAMC.NS income_statement (quarterly, 2026-06-30) — Total Unusual Items: 291732000.00
CRAMC.NS income_statement (quarterly, 2026-06-30) — Total Unusual Items Excluding Goodwill: 291732000.00
CRAN balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 24042.00
CRAN balance_sheet (quarterly, 2025-06-30) — Capital Stock: 958.00
CRAN balance_sheet (quarterly, 2025-06-30) — Common Stock: 958.00
CRAN balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 7580.00
CRAN balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 10677.00
CRAN balance_sheet (quarterly, 2025-06-30) — Current Assets: 20000.00
CRAN balance_sheet (quarterly, 2025-06-30) — Current Debt: 10420.00
CRAN balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 10420.00
CRAN balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 21097.00
CRAN balance_sheet (quarterly, 2025-06-30) — Invested Capital: 18000.00
CRAN balance_sheet (quarterly, 2025-06-30) — Net Debt: 10420.00
CRAN balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 7580.00
CRAN balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 8677.00
CRAN balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 40900000.00
CRAN balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 10420.00
CRAN balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 10677.00
CRAN balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
CRAN balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 20000.00
CRAN balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -17420.00
CRAN balance_sheet (quarterly, 2025-06-30) — Share Issued: 40900000.00
CRAN balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 7580.00
CRAN balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 7580.00
CRAN balance_sheet (quarterly, 2025-06-30) — Total Assets: 28677.00
CRAN balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 7580.00
CRAN balance_sheet (quarterly, 2025-06-30) — Total Debt: 10420.00
CRAN balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 7580.00
CRAN balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 21097.00
CRAN balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 8677.00
CRAN balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
CRAN balance_sheet (quarterly, 2025-06-30) — Working Capital: -1097.00
CRAN income_statement (quarterly, 2025-09-30) — +Operating Expense: 47900.00
CRAN income_statement (quarterly, 2025-09-30) — +Total Revenue: 0.00
CRAN balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 24042.00
CRAN income_statement (quarterly, 2025-09-30) — Basic Average Shares: 40900000.00
CRAN income_statement (quarterly, 2025-09-30) — Basic EPS: 0.00
CRAN cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 0.00
CRAN balance_sheet (quarterly, 2025-09-30) — Capital Stock: 958.00
CRAN balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 117045.00
CRAN balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 117045.00
CRAN balance_sheet (quarterly, 2025-09-30) — Cash Financial: 117045.00
CRAN cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 147525.00
CRAN cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -30480.00
CRAN cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 0.00
CRAN cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 0.00
CRAN cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 7000.00
CRAN cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 7000.00
CRAN cash_flow (quarterly, 2025-09-30) — Changes In Cash: 117045.00
CRAN balance_sheet (quarterly, 2025-09-30) — Common Stock: 958.00
CRAN balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: -22900.00
CRAN balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 39881.00
CRAN balance_sheet (quarterly, 2025-09-30) — Current Assets: 125419.00
CRAN balance_sheet (quarterly, 2025-09-30) — Current Debt: 158845.00
CRAN balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 158845.00
CRAN balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 198726.00
CRAN income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 40900000.00
CRAN income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.00
CRAN income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -47900.00
CRAN income_statement (quarterly, 2025-09-30) — EBIT: -47900.00
CRAN income_statement (quarterly, 2025-09-30) — EBITDA: -47900.00
CRAN cash_flow (quarterly, 2025-09-30) — End Cash Position: 117045.00
CRAN cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 147525.00
CRAN cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -30480.00
CRAN income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 47900.00
CRAN balance_sheet (quarterly, 2025-09-30) — Invested Capital: 135945.00
CRAN cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 148425.00
CRAN balance_sheet (quarterly, 2025-09-30) — Net Debt: 41800.00
CRAN income_statement (quarterly, 2025-09-30) — Net Income: -47900.00
CRAN income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -47900.00
CRAN income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -47900.00
CRAN income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -47900.00
CRAN income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -47900.00
CRAN cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -47900.00
CRAN income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -47900.00
CRAN cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 148425.00
CRAN cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -900.00
CRAN cash_flow (quarterly, 2025-09-30) — Net Short Term Debt Issuance: 148425.00
CRAN balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -22900.00
CRAN balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 50407.00
CRAN income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -47900.00
CRAN income_statement (quarterly, 2025-09-30) — Normalized Income: -47900.00
CRAN cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -30480.00
CRAN income_statement (quarterly, 2025-09-30) — Operating Income: -47900.00
CRAN income_statement (quarterly, 2025-09-30) — Operating Revenue: 0.00
CRAN balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 40900000.00
CRAN balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 158845.00
CRAN income_statement (quarterly, 2025-09-30) — Other Gand A: 47900.00
CRAN cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 10420.00
CRAN balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 39881.00
CRAN balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
CRAN balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 8374.00
CRAN income_statement (quarterly, 2025-09-30) — Pretax Income: -47900.00
CRAN balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -47900.00
CRAN income_statement (quarterly, 2025-09-30) — Selling General And Administration: 47900.00
CRAN balance_sheet (quarterly, 2025-09-30) — Share Issued: 40900000.00
CRAN cash_flow (quarterly, 2025-09-30) — Short Term Debt Issuance: 148425.00
CRAN balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: -22900.00
CRAN balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -22900.00
CRAN income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
CRAN income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
CRAN balance_sheet (quarterly, 2025-09-30) — Total Assets: 175826.00
CRAN balance_sheet (quarterly, 2025-09-30) — Total Capitalization: -22900.00
CRAN balance_sheet (quarterly, 2025-09-30) — Total Debt: 158845.00
CRAN balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: -22900.00
CRAN income_statement (quarterly, 2025-09-30) — Total Expenses: 47900.00
CRAN balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 198726.00
CRAN balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 50407.00
CRAN balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 0.00
CRAN balance_sheet (quarterly, 2025-09-30) — Working Capital: -73307.00
CRAN income_statement (quarterly, 2025-12-31) — +Operating Expense: 108155.00
CRAN income_statement (quarterly, 2025-12-31) — +Total Revenue: 0.00
CRAN balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 0.00
CRAN cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 117045.00
CRAN balance_sheet (annual, 2025-12-31) — Capital Stock: 345489219.00
CRAN balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 2194564.00
CRAN balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 2194564.00
CRAN balance_sheet (annual, 2025-12-31) — Cash Financial: 2194564.00
CRAN cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 347365556.00
CRAN cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -288037.00
CRAN cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 37763.00
CRAN cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 37763.00
CRAN cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -224645.00
CRAN cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -186882.00
CRAN cash_flow (quarterly, 2025-12-31) — Changes In Cash: 2077519.00
CRAN balance_sheet (annual, 2025-12-31) — Common Stock: 345489219.00
CRAN balance_sheet (annual, 2025-12-31) — Common Stock Equity: 333070381.00
CRAN balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 129807.00
CRAN balance_sheet (annual, 2025-12-31) — Current Assets: 2319165.00
CRAN balance_sheet (annual, 2025-12-31) — Current Liabilities: 129807.00
CRAN income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 379824.00
CRAN income_statement (quarterly, 2025-12-31) — EBIT: -108155.00
CRAN income_statement (quarterly, 2025-12-31) — EBITDA: -108155.00
CRAN cash_flow (quarterly, 2025-12-31) — End Cash Position: 2194564.00
CRAN cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 347365556.00
CRAN cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -288037.00
CRAN income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 108155.00
CRAN balance_sheet (annual, 2025-12-31) — Invested Capital: 333070381.00
CRAN cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 275.00
CRAN income_statement (quarterly, 2025-12-31) — Net Income: 379824.00
CRAN income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 379824.00
CRAN income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 379824.00
CRAN income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 379824.00
CRAN income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 379824.00
CRAN cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 379824.00
CRAN income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 379824.00
CRAN cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -158845.00
CRAN cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -475599.00
CRAN cash_flow (quarterly, 2025-12-31) — Net Short Term Debt Issuance: 275.00
CRAN balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 333070381.00
CRAN balance_sheet (annual, 2025-12-31) — Non Current Prepaid Assets: 93044.00
CRAN income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -108155.00
CRAN income_statement (quarterly, 2025-12-31) — Normalized Income: 379824.00
CRAN cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -288037.00
CRAN income_statement (quarterly, 2025-12-31) — Operating Income: -108155.00
CRAN income_statement (quarterly, 2025-12-31) — Operating Revenue: 0.00
CRAN balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 46900000.00
CRAN income_statement (quarterly, 2025-12-31) — Other Gand A: 108155.00
CRAN cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: -480979.00
CRAN balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 345487979.00
CRAN balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 129807.00
CRAN balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
CRAN balance_sheet (annual, 2025-12-31) — Prepaid Assets: 124601.00
CRAN income_statement (quarterly, 2025-12-31) — Pretax Income: 379824.00
CRAN balance_sheet (annual, 2025-12-31) — Retained Earnings: -12418838.00
CRAN income_statement (quarterly, 2025-12-31) — Selling General And Administration: 108155.00
CRAN balance_sheet (annual, 2025-12-31) — Share Issued: 46900000.00
CRAN cash_flow (quarterly, 2025-12-31) — Short Term Debt Issuance: 275.00
CRAN balance_sheet (annual, 2025-12-31) — Stockholders Equity: 333070381.00
CRAN balance_sheet (annual, 2025-12-31) — Tangible Book Value: 333070381.00
CRAN income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CRAN income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.21
CRAN balance_sheet (annual, 2025-12-31) — Total Assets: 347900188.00
CRAN balance_sheet (annual, 2025-12-31) — Total Capitalization: 333070381.00
CRAN balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 333070381.00
CRAN income_statement (quarterly, 2025-12-31) — Total Expenses: 108155.00
CRAN balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 14829807.00
CRAN balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 345581023.00
CRAN balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 14700000.00
CRAN balance_sheet (annual, 2025-12-31) — Tradeand Other Payables Non Current: 14700000.00
CRAN balance_sheet (annual, 2025-12-31) — Working Capital: 2189358.00
CRAN income_statement (quarterly, 2026-03-31) — +Operating Expense: 246313.00
CRAN income_statement (quarterly, 2026-03-31) — +Total Revenue: 0.00
CRAN balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 80196.00
CRAN balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 0.00
CRAN income_statement (quarterly, 2026-03-31) — Basic Average Shares: 46900000.00
CRAN income_statement (quarterly, 2026-03-31) — Basic EPS: 0.06
CRAN cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 2194564.00
CRAN balance_sheet (quarterly, 2026-03-31) — Capital Stock: 348540689.00
CRAN balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 1952555.00
CRAN balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 1952555.00
CRAN balance_sheet (quarterly, 2026-03-31) — Cash Financial: 1952555.00
CRAN cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -17044.00
CRAN cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -224965.00
CRAN cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 42433.00
CRAN cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -21085.00
CRAN cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 21348.00
CRAN cash_flow (quarterly, 2026-03-31) — Changes In Cash: -242009.00
CRAN balance_sheet (quarterly, 2026-03-31) — Common Stock: 348540689.00
CRAN balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 335875538.00
CRAN balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 75000.00
CRAN balance_sheet (quarterly, 2026-03-31) — Current Assets: 2122616.00
CRAN balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 155196.00
CRAN income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 46900000.00
CRAN income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.06
CRAN income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 2805157.00
CRAN income_statement (quarterly, 2026-03-31) — EBIT: -246313.00
CRAN income_statement (quarterly, 2026-03-31) — EBITDA: -246313.00
CRAN cash_flow (quarterly, 2026-03-31) — End Cash Position: 1952555.00
CRAN cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -17044.00
CRAN cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -224965.00
CRAN income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 246313.00
CRAN income_statement (quarterly, 2026-03-31) — Interest Income: 3051470.00
CRAN income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 3051470.00
CRAN balance_sheet (quarterly, 2026-03-31) — Invested Capital: 335875538.00
CRAN income_statement (quarterly, 2026-03-31) — Net Income: 2805157.00
CRAN income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 2805157.00
CRAN income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 2805157.00
CRAN income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 2805157.00
CRAN income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 2805157.00
CRAN cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 2805157.00
CRAN income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 2805157.00
CRAN income_statement (quarterly, 2026-03-31) — Net Interest Income: 3051470.00
CRAN income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 3051470.00
CRAN cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -17044.00
CRAN balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 335875538.00
CRAN balance_sheet (quarterly, 2026-03-31) — Non Current Prepaid Assets: 68669.00
CRAN income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -246313.00
CRAN income_statement (quarterly, 2026-03-31) — Normalized Income: 2805157.00
CRAN cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -224965.00
CRAN income_statement (quarterly, 2026-03-31) — Operating Income: -246313.00
CRAN income_statement (quarterly, 2026-03-31) — Operating Revenue: 0.00
CRAN balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 46900000.00
CRAN income_statement (quarterly, 2026-03-31) — Other Gand A: 246313.00
CRAN cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -3051470.00
CRAN balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 348539449.00
CRAN balance_sheet (quarterly, 2026-03-31) — Payables: 80196.00
CRAN balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 155196.00
CRAN balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
CRAN balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 170061.00
CRAN income_statement (quarterly, 2026-03-31) — Pretax Income: 2805157.00
CRAN balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -12665151.00
CRAN income_statement (quarterly, 2026-03-31) — Selling General And Administration: 246313.00
CRAN balance_sheet (quarterly, 2026-03-31) — Share Issued: 46900000.00
CRAN balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 335875538.00
CRAN balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 335875538.00
CRAN income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
CRAN income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
CRAN balance_sheet (quarterly, 2026-03-31) — Total Assets: 350730734.00
CRAN balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 335875538.00
CRAN balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 335875538.00
CRAN income_statement (quarterly, 2026-03-31) — Total Expenses: 246313.00
CRAN balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 14855196.00
CRAN balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 348608118.00
CRAN balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 14700000.00
CRAN income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -246313.00
CRAN balance_sheet (quarterly, 2026-03-31) — Tradeand Other Payables Non Current: 14700000.00
CRAN balance_sheet (quarterly, 2026-03-31) — Working Capital: 1967420.00
CRAP.PA cash_flow (annual, 2021-12-31) — Cash Dividends Paid: -10595000.00
CRAP.PA cash_flow (annual, 2021-12-31) — Common Stock Dividend Paid: -10595000.00
CRAP.PA cash_flow (annual, 2021-12-31) — Common Stock Issuance: 43039000.00
CRAP.PA balance_sheet (annual, 2021-12-31) — Investments In Other Ventures Under Equity Method: 0.00
CRAP.PA cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 43039000.00
CRAP.PA cash_flow (annual, 2021-12-31) — Other Cash Adjustment Outside Changein Cash: 1000.00
CRAP.PA balance_sheet (annual, 2021-12-31) — Other Payable: 74291000.00
CRAP.PA income_statement (annual, 2022-12-31) — +Operating Expense: 284715000.00
CRAP.PA income_statement (annual, 2022-12-31) — +Total Revenue: 450375000.00
CRAP.PA balance_sheet (annual, 2022-12-31) — Accounts Payable: 831968000.00
CRAP.PA balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -220274000.00
CRAP.PA income_statement (annual, 2022-12-31) — Amortization: 1000.00
CRAP.PA balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 1691765000.00
CRAP.PA income_statement (annual, 2022-12-31) — Basic Average Shares: 7444324.00
CRAP.PA income_statement (annual, 2022-12-31) — Basic EPS: 19.49
CRAP.PA cash_flow (annual, 2022-12-31) — Beginning Cash Position: 2593382000.00
CRAP.PA cash_flow (annual, 2022-12-31) — Capital Expenditure: -4390000.00
CRAP.PA balance_sheet (annual, 2022-12-31) — Capital Stock: 740062000.00
CRAP.PA balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 166574000.00
CRAP.PA balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Federal Funds Sold: 248956000.00
CRAP.PA cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -17346000.00
CRAP.PA balance_sheet (annual, 2022-12-31) — Cash Financial: 116874000.00
CRAP.PA cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -1290887000.00
CRAP.PA cash_flow (annual, 2022-12-31) — Change In Working Capital: -1290887000.00
CRAP.PA cash_flow (annual, 2022-12-31) — Changes In Cash: -1075850000.00
CRAP.PA balance_sheet (annual, 2022-12-31) — Common Stock: 740062000.00
CRAP.PA cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -17346000.00
CRAP.PA balance_sheet (annual, 2022-12-31) — Common Stock Equity: 2941899000.00
CRAP.PA cash_flow (annual, 2022-12-31) — Common Stock Issuance: 37470000.00
CRAP.PA cash_flow (annual, 2022-12-31) — Depreciation: 16683000.00
CRAP.PA cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 16683000.00
CRAP.PA income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 16686000.00
CRAP.PA income_statement (annual, 2022-12-31) — Depreciation Income Statement: 16685000.00
CRAP.PA balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 143986000.00
CRAP.PA income_statement (annual, 2022-12-31) — Diluted Average Shares: 7444324.00
CRAP.PA income_statement (annual, 2022-12-31) — Diluted EPS: 19.49
CRAP.PA income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 145076000.00
CRAP.PA cash_flow (annual, 2022-12-31) — Dividend Received Cfo: 0.00
CRAP.PA cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: 0.00
CRAP.PA cash_flow (annual, 2022-12-31) — End Cash Position: 1517532000.00
CRAP.PA balance_sheet (annual, 2022-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 383407000.00
CRAP.PA cash_flow (annual, 2022-12-31) — Financing Cash Flow: 31998000.00
CRAP.PA cash_flow (annual, 2022-12-31) — Free Cash Flow: -1103435000.00
CRAP.PA cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: -641000.00
CRAP.PA income_statement (annual, 2022-12-31) — Gain On Sale Of Security: -2230000.00
CRAP.PA income_statement (annual, 2022-12-31) — General And Administrative Expense: 86293000.00
CRAP.PA balance_sheet (annual, 2022-12-31) — Goodwill: 0.00
CRAP.PA balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 1000.00
CRAP.PA balance_sheet (annual, 2022-12-31) — Gross PPE: 338681000.00
CRAP.PA income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 0.00
CRAP.PA income_statement (annual, 2022-12-31) — Interest Expense: 204857000.00
CRAP.PA income_statement (annual, 2022-12-31) — Interest Income: 429124000.00
CRAP.PA balance_sheet (annual, 2022-12-31) — Invested Capital: 3328766000.00
CRAP.PA cash_flow (annual, 2022-12-31) — Investing Cash Flow: -8803000.00
CRAP.PA balance_sheet (annual, 2022-12-31) — Investment Properties: 81555000.00
CRAP.PA balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 2911361000.00
CRAP.PA balance_sheet (annual, 2022-12-31) — Investments And Advances: 2947116000.00
CRAP.PA balance_sheet (annual, 2022-12-31) — Investments In Other Ventures Under Equity Method: 35755000.00
CRAP.PA cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 37470000.00
CRAP.PA balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 455196000.00
CRAP.PA balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 35755000.00
CRAP.PA balance_sheet (annual, 2022-12-31) — Minority Interest: 89000.00
CRAP.PA income_statement (annual, 2022-12-31) — Minority Interests: 0.00
CRAP.PA cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -4413000.00
CRAP.PA cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 37470000.00
CRAP.PA balance_sheet (annual, 2022-12-31) — Net Debt: 220293000.00
CRAP.PA income_statement (annual, 2022-12-31) — Net Income: 145076000.00
CRAP.PA income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 145076000.00
CRAP.PA income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 145076000.00
CRAP.PA income_statement (annual, 2022-12-31) — Net Income Discontinuous Operations: 0.00
CRAP.PA income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 145076000.00
CRAP.PA income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 145076000.00
CRAP.PA cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 173088000.00
CRAP.PA income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 145076000.00
CRAP.PA income_statement (annual, 2022-12-31) — Net Interest Income: 224267000.00
CRAP.PA cash_flow (annual, 2022-12-31) — Net Other Financing Charges: 11874000.00
CRAP.PA balance_sheet (annual, 2022-12-31) — Net PPE: 118407000.00
CRAP.PA cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -4390000.00
CRAP.PA balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 2941898000.00
CRAP.PA income_statement (annual, 2022-12-31) — Normalized Income: 143747119.40
CRAP.PA cash_flow (annual, 2022-12-31) — Operating Cash Flow: -1099045000.00
CRAP.PA income_statement (annual, 2022-12-31) — Operating Revenue: 450375000.00
CRAP.PA balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 7444324.00
CRAP.PA balance_sheet (annual, 2022-12-31) — Other Equity Interest: 298330000.00
CRAP.PA balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 1000.00
CRAP.PA cash_flow (annual, 2022-12-31) — Other Non Cash Items: 701000.00
CRAP.PA income_statement (annual, 2022-12-31) — Other Operating Expenses: 13157000.00
CRAP.PA balance_sheet (annual, 2022-12-31) — Other Payable: 99029000.00
CRAP.PA income_statement (annual, 2022-12-31) — Other Special Charges: -641000.00
CRAP.PA balance_sheet (annual, 2022-12-31) — Payables: 931003000.00
CRAP.PA balance_sheet (annual, 2022-12-31) — Prepaid Assets: 5201000.00
CRAP.PA income_statement (annual, 2022-12-31) — Pretax Income: 173088000.00
CRAP.PA cash_flow (annual, 2022-12-31) — Provisionand Write Offof Assets: 32521000.00
CRAP.PA balance_sheet (annual, 2022-12-31) — Receivables: 294962000.00
CRAP.PA income_statement (annual, 2022-12-31) — Reconciled Depreciation: 16683000.00
CRAP.PA balance_sheet (annual, 2022-12-31) — Retained Earnings: 145076000.00
CRAP.PA income_statement (annual, 2022-12-31) — Selling General And Administration: 86293000.00
CRAP.PA balance_sheet (annual, 2022-12-31) — Share Issued: 7452389.00
CRAP.PA income_statement (annual, 2022-12-31) — Special Income Charges: 644000.00
CRAP.PA balance_sheet (annual, 2022-12-31) — Stockholders Equity: 2941899000.00
CRAP.PA balance_sheet (annual, 2022-12-31) — Tangible Book Value: 2941898000.00
CRAP.PA income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 264119.40
CRAP.PA income_statement (annual, 2022-12-31) — Tax Provision: 28012000.00
CRAP.PA income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.17
CRAP.PA balance_sheet (annual, 2022-12-31) — Taxes Receivable: 11067000.00
CRAP.PA cash_flow (annual, 2022-12-31) — Taxes Refund Paid: -26360000.00
CRAP.PA balance_sheet (annual, 2022-12-31) — Total Assets: 26384732000.00
CRAP.PA balance_sheet (annual, 2022-12-31) — Total Capitalization: 3328766000.00
CRAP.PA balance_sheet (annual, 2022-12-31) — Total Debt: 455196000.00
CRAP.PA balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 2941988000.00
CRAP.PA balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 23442744000.00
CRAP.PA balance_sheet (annual, 2022-12-31) — Total Tax Payable: 6000.00
CRAP.PA income_statement (annual, 2022-12-31) — Total Unusual Items: 1593000.00
CRAP.PA income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 1593000.00
CRAP.PA balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 8065.00
CRAP.PA income_statement (annual, 2022-12-31) — Write Off: -3000.00
CRAP.PA income_statement (annual, 2023-12-31) — +Operating Expense: 289043000.00
CRAP.PA income_statement (annual, 2023-12-31) — +Total Revenue: 428858000.00
CRAP.PA balance_sheet (annual, 2023-12-31) — Accounts Payable: 445642000.00
CRAP.PA balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -232807000.00
CRAP.PA income_statement (annual, 2023-12-31) — Amortization: 0.00
CRAP.PA balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 1878688000.00
CRAP.PA income_statement (annual, 2023-12-31) — Basic Average Shares: 7443159.00
CRAP.PA income_statement (annual, 2023-12-31) — Basic EPS: 15.64
CRAP.PA cash_flow (annual, 2023-12-31) — Beginning Cash Position: 1517532000.00
CRAP.PA cash_flow (annual, 2023-12-31) — Capital Expenditure: -8133000.00
CRAP.PA balance_sheet (annual, 2023-12-31) — Capital Stock: 727543000.00
CRAP.PA balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 110908000.00
CRAP.PA balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Federal Funds Sold: 110908000.00
CRAP.PA balance_sheet (annual, 2023-12-31) — Cash Financial: 100966000.00
CRAP.PA cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -756064000.00
CRAP.PA cash_flow (annual, 2023-12-31) — Change In Working Capital: -756064000.00
CRAP.PA cash_flow (annual, 2023-12-31) — Changes In Cash: -721991000.00
CRAP.PA balance_sheet (annual, 2023-12-31) — Common Stock: 727543000.00
CRAP.PA balance_sheet (annual, 2023-12-31) — Common Stock Equity: 3167604000.00
CRAP.PA cash_flow (annual, 2023-12-31) — Depreciation: 15584000.00
CRAP.PA cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 15584000.00
CRAP.PA income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 15584000.00
CRAP.PA income_statement (annual, 2023-12-31) — Depreciation Income Statement: 15584000.00
CRAP.PA balance_sheet (annual, 2023-12-31) — Derivative Product Liabilities: 164415000.00
CRAP.PA income_statement (annual, 2023-12-31) — Diluted Average Shares: 7443159.00
CRAP.PA income_statement (annual, 2023-12-31) — Diluted EPS: 15.64
CRAP.PA income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 116402000.00
CRAP.PA cash_flow (annual, 2023-12-31) — Dividend Received Cfo: 0.00
CRAP.PA cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 0.00
CRAP.PA cash_flow (annual, 2023-12-31) — End Cash Position: 795541000.00
CRAP.PA balance_sheet (annual, 2023-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 360493000.00
CRAP.PA cash_flow (annual, 2023-12-31) — Financing Cash Flow: -79184000.00
CRAP.PA cash_flow (annual, 2023-12-31) — Free Cash Flow: -636427000.00
CRAP.PA cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: 434000.00
CRAP.PA income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 6518000.00
CRAP.PA income_statement (annual, 2023-12-31) — General And Administrative Expense: 88076000.00
CRAP.PA balance_sheet (annual, 2023-12-31) — Goodwill: 0.00
CRAP.PA balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 1000.00
CRAP.PA balance_sheet (annual, 2023-12-31) — Gross PPE: 336454000.00
CRAP.PA income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 0.00
CRAP.PA income_statement (annual, 2023-12-31) — Interest Expense: 608007000.00
CRAP.PA income_statement (annual, 2023-12-31) — Interest Income: 765421000.00
CRAP.PA balance_sheet (annual, 2023-12-31) — Invested Capital: 3828847000.00
CRAP.PA cash_flow (annual, 2023-12-31) — Investing Cash Flow: -14513000.00
CRAP.PA balance_sheet (annual, 2023-12-31) — Investment Properties: 96005000.00
CRAP.PA balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 3205545000.00
CRAP.PA balance_sheet (annual, 2023-12-31) — Investments And Advances: 3244840000.00
CRAP.PA balance_sheet (annual, 2023-12-31) — Investments In Other Ventures Under Equity Method: 39295000.00
CRAP.PA balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 716146000.00
CRAP.PA balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 39295000.00
CRAP.PA balance_sheet (annual, 2023-12-31) — Minority Interest: 601000.00